Hemostasis activation during sclerotherapy of lower extremity varices

Thrombosis Research

Volumn 82, Issue 1, 1996, Pages 87-95

  Ikeda, Masataka ^a   Kambayashi, Jun Ichi ^a   Iwamoto, Shin Ichi ^a   Shinoki, Nobutoshi ^a   Nakamura, Takashi ^a   Okahara, Kazuhiro ^a   Fujitani, Kazumasa ^a   Shibuya, Takashi ^a   Kawasaki, Tomio ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

compression sclerotherapy; hemostasis activation; throbmin antithrombin III complexes (TAT)

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; SODIUM CHLORIDE; THROMBIN ANTITHROMBIN III COMPLEX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPRESSION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY; THROMBOEMBOLISM; VARICOSIS;

EID: 9344252287     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00054-0     Document Type: Article

References (21)

1. GOLDMAN, M.P., WEISS, R.A. and BERGAN, J.J. Diagnosis and treatment of varicose veins: a review. J Am Acad Dermatol 31, 393-413, 1994.
2. MARLEY, W.M. and MARLEY, N.F. Sclerotherapy treatment of varicose veins. Semin Dermatol 12, 98-101, 1993.
3. GOLDMAN, M.P. Compression sclerotherapy and its complications. In: Venous disorders. J.B. Bergan, J.S.T. Yao (ed.), pp. 233-249, W.B. Saunders, Philadelphia (1991)
4. TOTH, L.M. and VAN DER MILEN, H.R. Les complications thromboemboliques apres traitement sclerosant de varices. Phlebologie 25, 425-430, 1972.
5. SIGG, K. Zur behandlung der varizen der phlebitis und ihrer komplikationen. Dermatologica 100, 315-320, 1950.
6. PERRAULT, M., DUCHESNAY, G. and GRIESSER, J. Les accidents therapeutiques relevant de la prise prolongee ou inconsideree de medicaments d'usage courand. Rev Prat 15, 1319-1327, 1965.
7. FEIED, C.F. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states. Semin Dermatol 12, 135-149, 1993.
8. KANG, J.H., KAMBAYASHI, J., SAKON, M., SHIOZAKI, H., OGAWA, Y., OHSHIRO, T. and MORI, T. Mechanism of the haemostatic effect of ethanolamine oleate in the injection sclerotherapy for oesophageal varices. Br J Surg 74, 50-53, 1987.
9. FUJII, Y., SUGAWA, C., OZAWA, T., NAKAMURA, R., BROWN-CASTILLO, J. and MAMMEN, E.F. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics Am Surg 57, 222-225, 1991.
10. HASHIZUME, M., YAMAGA, H. and SUGIMACHI, K. Hypercoagulopathy after repeated injection of 5% ethanolamine oleate to sclerose esophageal varices. Hepato-gastroenterol 37, 565-568, 1990.
11. PELZER, H., SCHWARZ, A. and HEIMBURGER, N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay Thromb Heamostas 59, 101-106, 1988.
12. HEATON, D.C., BILLINGS, J.D. and HICKTON, C.M. Assessment of D dimer assays for the diagnosis of deep vein thrombosis. J Lab Clin Med 110, 588-591, 1987.
13. OTT, P., ASTRUP, L., JENSEN, R.H., NYELAND, B. and PEDERSEN, B. Assessment of D-dimer in plasma: diagnostic value in suspected deep venous thrombosis of the leg. Acta Med Scand 224, 263-267, 1988.
14. ESTIVALS, M., PELZER, H., SIE, P., PICHON, J., BOCCALON, H. and BONEU, B. Prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatment. Br J Heamatol 78, 421 -424, 1991.
15. TAKADA, K., MATSUMOTO, A., MIYOSHI, H. and OSHIBA, S. Changes in thrombin-antithrombin III complex after endoscopic injection sclerotherapy. Am J Gastroenterol 86, 123-124, 1991.
16. BICK, R.L. and UCAR, K. Hypercoagulability and thrombosis. Hemato/Onco Clin North Am 6, 1421-1431, 1992.
17. SKILLMAN J.J. Superficial venous thrombosis and septic thrombophlebitis. In: Vascular Surgery of the Lower Extremity. F. Jarrett and S. Hirsch (eds), pp. 239-243, The C. V. Mosby Company, St. Louis (1985).
18. GREEN, D. Mechanism of action of sclerotherapy. Semin Dermatol 12, 88-97, 1993.
19. CACCIOLA, E., GIUSTOLISI, R., MUSSO, R., VECCHIO, R., LONGO, A., TRIOLO, A. and CACCIOLA, R.R. Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction J Lab Clin Med 109, 225-226, 1987.
20. NACHMAN, R.L. and SILVERSTEIN, R. Hypercoagulable states. Ann Intern Med 119, 819-827, 1993.
21. MELISSARI, E., MONTE, G., LINDO, V.S., PEMBERTON, K.D., WILSON, N.V., EDMONSON, R., DAS, S. and KAKKAR, V.V. Congenital thrombophilia among patients with venous thromboembolism. Blood Coagulation and Fibrinolysis 3, 749-758, 1992.